Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Immuneering Corporation
Market Cap
$139.95M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$139.73M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$141.82M
Interest Coverage Ratio
-2.75x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$138.31M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.48M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$136.91M
Interest Coverage Ratio
N/A
TTM Avg
346.24x
3Y Avg
936.28x
5Y Avg
577.46x
Market Cap
$144.19M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$135.65M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immuneering Corporation (IMRX) | $139.95M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | -8.06x | N/A | N/A | N/A |
| Sutro Biopharma, Inc. (STRO)vs › | $141.82M | -2.75x | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $138.31M | N/A | N/A | N/A | N/A |
| Protara Therapeutics, Inc. (TARA)vs › | $142.48M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.10M | -49.05x | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.91M | N/A | 346.24x | 936.28x | 577.46x |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.19M | N/A | N/A | N/A | N/A |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.65M | N/A | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $135.08M | N/A | N/A | N/A | N/A |
Interest Coverage
N/A
Debt/Equity
0.02
Current Ratio
19.47
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
